JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 3, 2004; DOI: 10.1124/jpet.104.072553


0022-3565/04/3113-1097-1104$20.00
JPET 311:1097-1104, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.072553v1
311/3/1097    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heacock, A. M.
Right arrow Articles by Fisher, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heacock, A. M.
Right arrow Articles by Fisher, S. K.

NEUROPHARMACOLOGY

Potentiation of the Osmosensitive Release of Taurine and D-Aspartate from SH-SY5Y Neuroblastoma Cells after Activation of M3 Muscarinic Cholinergic Receptors

Anne M. Heacock, Daniel Kerley, Grzegorz T. Gurda, Aaron T. VanTroostenberghe, and Stephen K. Fisher

Mental Health Research Institute (A.M.H., D.K., G.T.G., A.T.V., S.K.F.) and Department of Pharmacology (S.K.F.), University of Michigan, Ann Arbor, Michigan

The ability of muscarinic cholinergic receptors (mAChRs) to regulate the volume-sensitive efflux of two organic osmolytes, namely, taurine and D-aspartate, from human SH-SY5Y neuroblastoma cells has been examined. Incubation of the cells with hypoosmolar buffers resulted in an efflux of both osmolytes, with the threshold for release occurring at approximately 225 mOsM for taurine and D-aspartate. Inclusion of oxotremorine-M (Oxo-M), a muscarinic agonist, resulted in a marked enhancement of the volume-dependent efflux of both osmolytes and increased the threshold osmolarity for taurine and D-aspartate release to 340 (isotonic) and 320 mOsM, respectively. Maximum agonist stimulation of osmolyte release (350% of basal) was observed in the range of 225 to 250 mOsM. Oxo-M-stimulated osmolyte efflux was inhibited by muscarinic antagonists with a rank order of potency 4-diphenylacetoxy-N-methylpiperidine methiodide > pirenzepine > 11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one, a pharmacological profile identical to that obtained for M3 mAChR-stimulated phosphoinositide hydrolysis. Agonist-stimulated efflux of both osmolytes could be inhibited by inclusion of either anion channel blockers known to inhibit the volume-sensitive organic anion channel (VSOAC) or by a tyrosine kinase inhibitor {alpha}-cyano-(3,4-dihydroxy)cinnamonitrile. The results indicate that the activation of M3 mAChRs on SH-SY5Y neuroblastoma facilitates the ability of these cells to respond to very limited reductions in osmolarity via a release of osmolytes. mAChR-stimulated osmolyte efflux is mediated via a VSOAC and seems to require the activity of a tyrosine kinase.


Received June 10, 2004; accepted July 30, 2004.

Address correspondence to: Dr. Stephen K. Fisher, Mental Health Research Institute Laboratories at MSRB II, 1150 West Medical Center Dr., C560, MSRB II, University of Michigan, Ann Arbor, MI 48109-0669. E-mail: skfisher{at}umich.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. J. Foster, A. M. Heacock, R. F. Keep, and S. K. Fisher
Activation of Muscarinic Cholinergic Receptors on Human SH-SY5Y Neuroblastoma Cells Enhances Both the Influx and Efflux of K+ under Conditions of Hypo-Osmolarity
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Cheema and S. K. Fisher
Cholesterol Regulates Volume-Sensitive Osmolyte Efflux from Human SH-SY5Y Neuroblastoma Cells following Receptor Activation
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 648 - 657.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Cheema, V. A. Pettigrew, and S. K. Fisher
Receptor Regulation of the Volume-Sensitive Efflux of Taurine and Iodide from Human SH-SY5Y Neuroblastoma Cells: Differential Requirements for Ca2+ and Protein Kinase C
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1068 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Heacock, D. J. Foster, and S. K. Fisher
Prostanoid Receptors Regulate the Volume-Sensitive Efflux of Osmolytes from Murine Fibroblasts via a Cyclic AMP-Dependent Mechanism
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 963 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Heacock, M. S. Dodd, and S. K. Fisher
Regulation of Volume-Sensitive Osmolyte Efflux from Human SH-SY5Y Neuroblastoma Cells following Activation of Lysophospholipid Receptors
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 685 - 693.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Cheema, C. E. Ward, and S. K. Fisher
Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 755 - 763.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.